Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

The multiple roles of Fas ligand in the pathogenesis of infectious diseases.

Dockrell DH.

Clin Microbiol Infect. 2003 Aug;9(8):766-79. Review.

2.

Upregulated expression of Fas and Fas ligand in brain through the spectrum of HIV-1 infection.

Elovaara I, Sabri F, Gray F, Alafuzoff I, Chiodi F.

Acta Neuropathol. 1999 Oct;98(4):355-62.

PMID:
10502040
3.

Fas and Fas ligand in gut and liver.

Pinkoski MJ, Brunner T, Green DR, Lin T.

Am J Physiol Gastrointest Liver Physiol. 2000 Mar;278(3):G354-66. Review.

4.

Fas/Fas ligand on the road: an apoptotic pathway common to AIDS, autoimmunity, lymphoproliferation and transplantation.

Famularo G, Nucera E, Marcellini S, De Simone C.

Med Hypotheses. 1999 Jul;53(1):50-62.

PMID:
10499826
5.

Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack.

Maher S, Toomey D, Condron C, Bouchier-Hayes D.

Immunol Cell Biol. 2002 Apr;80(2):131-7. Review.

6.

Fas-mediated apoptosis in tumor formation and defense.

Hug H.

Biol Chem. 1997 Dec;378(12):1405-12. Review.

PMID:
9461339
7.
8.

Perforin and Fas act together in the induction of apoptosis, and both are critical in the clearance of lymphocytic choriomeningitis virus infection.

Rode M, Balkow S, Sobek V, Brehm R, Martin P, Kersten A, Dumrese T, Stehle T, Müllbacher A, Wallich R, Simon MM.

J Virol. 2004 Nov;78(22):12395-405.

9.

Role of FAS in HIV infection.

Dianzani U, Bensi T, Savarino A, Sametti S, Indelicato M, Mesturini R, Chiocchetti A.

Curr HIV Res. 2003 Oct;1(4):405-17. Review.

PMID:
15049427
10.

Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.

Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.

Cell Immunol. 2006 Feb;239(2):121-8. Erratum in: Cell Immunol. 2006 Oct;243(2):127.

PMID:
16808908
11.

The Fas signalling pathway and its role in the pathogenesis of cancer.

Houston A, O'Connell J.

Curr Opin Pharmacol. 2004 Aug;4(4):321-6. Review.

PMID:
15251123
12.

Up-regulation of Fas ligand expression by human cytomegalovirus immediate-early gene product 2: a novel mechanism in cytomegalovirus-induced apoptosis in human retina.

Chiou SH, Liu JH, Hsu WM, Chen SS, Chang SY, Juan LJ, Lin JC, Yang YT, Wong WW, Liu CY, Lin YS, Liu WT, Wu CW.

J Immunol. 2001 Oct 1;167(7):4098-103.

13.

Fas ligand is required for resolution of granulomatous experimental autoimmune thyroiditis.

Wei Y, Chen K, Sharp GC, Braley-Mullen H.

J Immunol. 2004 Dec 15;173(12):7615-21.

14.

Autoimmune diabetes in the NOD mouse: an essential role of Fas-FasL signaling in beta cell apoptosis.

Silva DG, Socha L, Charlton B, Cowden W, Petrovsky N.

Ann N Y Acad Sci. 2003 Nov;1005:161-5.

PMID:
14679051
15.

Fas and Fas ligand interactions in malignant disease.

Owen-Schaub L, Chan H, Cusack JC, Roth J, Hill LL.

Int J Oncol. 2000 Jul;17(1):5-12. Review.

PMID:
10853011
16.

The Fas system in the seminiferous epithelium and its possible extra-testicular role.

Riccioli A, Salvati L, D'Alessio A, Starace D, Giampietri C, De Cesaris P, Filippini A, Ziparo E.

Andrologia. 2003 Feb;35(1):64-70. Review.

PMID:
12558530
17.

New kids in the block: the role of FasL and Fas in kidney damage.

Ortiz A, Lorz C, Egido J.

J Nephrol. 1999 May-Jun;12(3):150-8. Review.

PMID:
10440512
18.

Fas ligand is localized to membrane rafts, where it displays increased cell death-inducing activity.

Cahuzac N, Baum W, Kirkin V, Conchonaud F, Wawrezinieck L, Marguet D, Janssen O, Zörnig M, Hueber AO.

Blood. 2006 Mar 15;107(6):2384-91.

19.

Fas/FasL interaction: a novel immune therapy approach with immobilized biologicals.

Scholz M, Cinatl J.

Med Res Rev. 2005 May;25(3):331-42. Review.

PMID:
15599929
20.

Induction of tolerance using Fas ligand: a double-edged immunomodulator.

Askenasy N, Yolcu ES, Yaniv I, Shirwan H.

Blood. 2005 Feb 15;105(4):1396-404. Review.

Supplemental Content

Support Center